BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11396153)

  • 1. Effects of retinoic acid and amifostine on in vitro growth of normal hemopoietic progenitor cells.
    Arboscello E; Botta M; Romero D; Schenone E; Mencoboni M; Bogliolo G; Pannacciulli I
    Anticancer Res; 2001; 21(2A):1139-43. PubMed ID: 11396153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine exerts anti-angiogenic activity and suppresses vascular endothelial growth factor secreted by hemopoietic stem/progenitor cells.
    Akel SM; Atoum MF; Saleh SA; Awadallah SM
    Saudi Med J; 2005 Oct; 26(10):1523-8. PubMed ID: 16228049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effects of amifostine on hematopoietic stem/progenitor cells against chemotherapeutic damage].
    Chen BA; Li CP; Zhou M; Gao C; Ding JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):803-6. PubMed ID: 15631665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amifostine promotes hemopoietic progenitor cell mobilization in patients with myelodysplastic syndrome.
    Arboscello E; Botta M; Lerza R; Bogliolo G; Clavio M; Miglino M; Mencoboni M; Pannacciulli I
    Anticancer Res; 2002; 22(3):1819-24. PubMed ID: 12168875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome.
    De Francesco A; Sanavio F; Stacchini A; Piacibello W; Quaglino D; Aglietta M
    Haematologica; 1989; 74(1):25-8. PubMed ID: 2498179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
    Viniou N; Terpos E; Galanopoulos A; Kritikou-Griva E; Akel S; Michalis E; Apostolidou E; Georgiadou D; Kouraklis A; Parharidou A; Kokkini G; Symeonidis A; Anagnostopoulos NI; Christakis JI; Tasiopoulou A; Loukopoulos D; Yataganas X
    Ann Hematol; 2002 Apr; 81(4):182-6. PubMed ID: 11976818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifostine as differentiating agent in cord blood and bone marrow cultures from children with hematological disorders.
    Danilatou V; Dimitriou H; Stiakaki E; Kalmanti M
    Pediatr Hematol Oncol; 2004 Mar; 21(2):125-34. PubMed ID: 15160511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
    J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M
    Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid (ATRA) enhances maintenance of primitive human hematopoietic progenitors and skews them towards myeloid differentiation in a stroma-noncontact culture system.
    Leung AY; Verfaillie CM
    Exp Hematol; 2005 Apr; 33(4):422-7. PubMed ID: 15781332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular biological mechanism of leukocytosis produced by all-trans retinoic acid: a preliminary study].
    Chen H; Sun G; Li J
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):284-6. PubMed ID: 10923486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of hypoxia on the proliferation and differentiation of CD34(+) hematopoietic stem/progenitor cells and their response to cytokines].
    Sun B; Bai CX; Feng K; Li L; Zhao P; Pei XT
    Sheng Li Xue Bao; 2000 Apr; 52(2):143-6. PubMed ID: 11961584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.
    Pierelli L; Scambia G; Fattorossi A; Bonanno G; Battaglia A; Perillo A; Menichella G; Panici PB; Leone G; Mancuso S
    Br J Cancer; 1998 Oct; 78(8):1024-9. PubMed ID: 9792145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
    Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
    Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
    Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ; Zheng J
    Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.